Company news

Tempus AI, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2

July 31, 2024

Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics

July 29, 2024

GeneCentric Therapeutics Announces American Medical Association Has Granted a PLA Code for PurIST Pancreatic Cancer Test

July 23, 2024

Tempus to Report Second Quarter 2024 Financial Results on August 6

July 16, 2024

Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests

July 15, 2024

Tempus Surpasses 500 Research Publications

July 9, 2024

American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM

July 7, 2024

CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test

July 1, 2024

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib

June 25, 2024

Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension

June 24, 2024

Tempus Announces Pricing of Initial Public Offering

June 12, 2024

← Newer news releases

Calls

The 5 newest of 10 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.